The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
QUALITY OF LIFE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER: DIFFERENCES BASED ON TREATMENT MODALITY
Abstract
PURPOSE: Brachytherapy with 103palladium (103Pd) is an increasingly administered treatment modality for localized prostate cancer. We compared general and disease specific health related quality of life after 103Pd treatment, radical prostatectomy and external beam radiation therapy given during the same time frame. MATERIALS AND METHODS: We performed a retrospective cross-sectional survey study of patients treated at a single community medical center between 1995 and 1999. We mailed 5 validated health related quality of life survey instruments to 269, 142 and 222 men who underwent radical prostatectomy, 103Pd treatment and external beam radiation therapy, respectively, with a response rate of greater than 80% in all groups. RESULTS: General health related quality of life assessed by the SF-36 showed the same scores in patients who underwent prostatectomy and 103Pd treatment. The University of California-Los Angeles Prostate Cancer Index was used to assess bowel, urinary and sexual function/bothersomeness. External beam radiation therapy reported was associated with worse bowel function and greater bowel bothersomeness. Prostatectomy was associated with worse urinary function compared to 103Pd and external beam radiation therapy. Prostatectomy was associated with worse sexual function than 103Pd or external beam radiation therapy, although nerve sparing surgery and erectile aids minimized the difference. American Urological Association symptom scores were initially higher for 103Pd but became equal to those in the other groups in patients treated greater than 12 months from survey time. Disease-free men who underwent prostatectomy and 103Pd brachytherapy were equally confident that cancer would not recur in the future. Satisfaction rates were equivalent and biochemical failure significantly decreased satisfaction in all groups. CONCLUSIONS: While general health related quality of life was mostly unaffected by the 3 most common treatments for prostate cancer, there were differences in bowel, urinary and sexual function. This information may aid patients in the decision making process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.1995.03520260051032 · Cited by 1,020
QUALITY OF LIFE OUTCOMES AFTER BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER
BRANDEIS, J. M., LITWIN, M. S., BURNISON, C. M., & REITER, R. E. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67818-4 · Cited by 188
Cited by
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
Self-citationQuality of life after treatment for prostate cancer
Penson, D. F., & Litwin, M. S. (2003) · Current Urology Reports · doi:10.1007/s11934-003-0068-1 · Cited by 71
Ştefănuţ, A. M., Vintilă, M., & Sârbescu, P. (2021) · European Journal of Cancer Care · doi:10.1111/ecc.13374 · Cited by 10
Metadata
- Authors
- DAVIS, J. W., KUBAN, D. A., LYNCH, D. F., & SCHELLHAMMER, P. F.
- Venue
- Journal of Urology
- Published
- 2001-09
- Volume
- 166
- Issue
- 3
- Pages
- 947-952
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W1981976495
- Cited by
- 163
- References
- 2
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: QUALITY OF LIFE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER: DIFFERENCES BASED ON TREATMENT MODALITY. https://app.cochat.ai/papers/10.1016/s0022-5347(05)65870-3
- The paper
- DAVIS, J. W., KUBAN, D. A., LYNCH, D. F., & SCHELLHAMMER, P. F. (2001). QUALITY OF LIFE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER: DIFFERENCES BASED ON TREATMENT MODALITY. Journal of Urology. https://doi.org/10.1016/s0022-5347(05)65870-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.